# Determinants of the Progression and Outcome of Mitral Regurgitation

> **NCT01835054** · — · UNKNOWN · sponsor: **Laval University** · enrollment: 440 (estimated)

## Conditions studied

- Mitral Valve Insufficiency

## Interventions

- **OTHER:** Blood biomarkers
- **GENETIC:** DNA collection
- **OTHER:** Echocardiography
- **OTHER:** Cardiopulmonary exercise testing
- **OTHER:** Magnetic resonance imaging (MRI)
- **OTHER:** Exercise stress doppler echocardiography
- **OTHER:** Holter ECG

## Key facts

- **NCT ID:** NCT01835054
- **Lead sponsor:** Laval University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-12
- **Primary completion:** 2024-03
- **Final completion:** 2024-03
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2021-10-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01835054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01835054, "Determinants of the Progression and Outcome of Mitral Regurgitation". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01835054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
